EE128 Cost-Effectiveness of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Vs. Entecavir for Chronic Hepatitis B Patients in Greece

E. Sinakos, N. Kachru, C. Tsoulas, S. Jeyakumar, N. Smith, A. Yehoshua,E. Cholongitas

Value in Health（2023）

引用 0|浏览0

暂无评分

摘要

This study aimed to assess the cost-effectiveness of switching from TDF to TAF (TDF→TAF) versus switching to ETV (TDF→ETV) in the treatment of Greek CHB patients > 60 years.

查看译文

关键词

tenofovir disoproxil fumarate,tenofovir alafenamide vs,cost-effectiveness

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要